References

by Ben Ong

Here is a list of all of the medical journals and studies that we reference in order to back up everything we publish. We use only the peer-reviewd and double-blind scientific studies and evidence from a wide array of different sources to ensure that the information we publish is completely independent.

Dai, Xiaoyu, et al. “Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.” Medicine 95.18 (2016).

Cancer Research 59 (1999), pp. 4161-64

American J. Clinical Oncology 20 (1997, pp. 605-08)

Hubei Yike Daxue Xuebao 19 (1998), pp. 241-42

Prostate 44 (2000), pp. 219-24

Journal of Urology 169 (2003), pp. 1312-15

Prostate 47 (2001), pp. 52-58

Journal of the American Medical Assoc. 276 (1996), pp. 1904-06

Journal of Urology 144 (1989), pp. 1139–42

Cancer Epidem., Biomarkers & Preview 6 (1997), pp. 967-69

Journal of the American Medical Assoc. 265 (1991), pp. 618-21

Journal Clinical Endocrin. Med. 82 (1997), pp. 571-75

European Journal of Cancer 20 (1984), pp.477-82

Experientia 35 (1978), pp. 844-45

Drugs and Ageing 17 (2000), pp. 431-39

Prostate 3 (1982), pp. 579—88

British Journal of Urology 77 (1996), pp. 433–40

Prostate 6 (1985), pp. 12128; and Journal of Clinical Endocrinology & Metabolism 54 (1982), pp. 1104-08

Prostate 4 (1983), pp. 223-29

Journal of Clinical Endoc. & Metabolism 15 (1954), pp. 297–30

Cancer 86 (1999), pp. 312-15

Prostate Cancer 3 (2000), pp. 157-72

Int. J. Cancer 108 (2003) pp. 418-24

Journal of Urology 170 (2003) pp. 2348-51

Acta Endoc. 98 (1981) pp. 634-40

Prostate 12 (1988) pp. 325-32

  1. Clin. Endoc. Metab. 77 (1993) pp. 375-81

Prostate 11 (1987) pp. 171-82

  1. Urol. 159 (1998) p. 441-3
  2. Urol 156 (1996) pp. 438-42

Acta Endocrinologica 90 (1979), pp. 77-36

Prostate 26 (1995), pp. 40-49

Journal of Surgical Oncology 59 (1995), pp. 246-50

Drugs 55(1998), pp. 253-58

European Urology 41 (2002), pp. 113-20

Clinical Endocrinology 50 (1999), pp. 629-35

Cancer Epidimiology Biomarkers & Preview 4 (1995), pp.735-41

British Journal of Medicine 4 (1971), pp. 391-94

Hejishu 16 (1993), pp. 649-52

Cancer 83 (1998), pp.1170-73

Cancer 65 (1990), pp. 2758-61

Cancer Epidemiology Biomarkers & Preven. 2 (1993), pp. 219-21

Akad. Med. Bialymstoku Supp. 42 (1984), p. 17

Journal of Urology 99 (1968), p. 788-92

Cancer Research 42 (1982), pp. 3864-69

Scand. J. Urol. Nephrol. 157 (1994) pp. 41-7

Journal of Andrology 23 (2002) pp. 419-25

Ageing Male 6 (2003) pp.207-11

Urology 49 (1997) pp. 191-6

Journal of Urology 141 (1989) pp. 1139-42

Surgical Forum 28 (1977) pp. 568-9

Oncology 37 (1980) pp. 46-52

Urology 33 Supp. (1989) pp. 53-6

New England Journal of Medicine 350 (2004) pp.482-92

Journal of Urology 146 (1991) pp. 372-6

Hu, Hui et al. “Racial Differences In Age-Related Variations Of Testosterone Levels Among US Males: Potential Implications For Prostate Cancer And Personalized Medication”. J. Racial and Ethnic Health Disparities 2.1 (2014): 69-76. Web.
Pagano MJ, et al. “Age, Body Mass Index And Frequency Of Sexual Activity Are Independent Predictors Of Testosterone Deficiency In Men With Erectile Dysfunction. – Pubmed – NCBI”.Ncbi.nlm.nih.gov. N.p., 2016. Web. 9 June 2016.
Rebbeck, Timothy R. et al. “Global Patterns Of Prostate Cancer Incidence, Aggressiveness, And Mortality In Men Of African Descent”. Prostate Cancer 2013 (2013): 1-12. Web.

Parsons, J. Kellogg et al. “Obesity And Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms And Future Directions”. The Journal of Urology 189.1 (2013): S102-S106. Web.
Fwu, Chyng-Wen et al. “Change In Sexual Function In Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Associated With Long-Term Treatment With Doxazosin, Finasteride And Combined Therapy”. The Journal of Urology 191.6 (2014): 1828-1834. Web.
HOFFMAN, MICHAEL A., WILLIAM C. DeWOLF, and ABRAHAM MORGENTALER. “IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?”. The Journal of Urology (2000): 824. Web.
Khera, Mohit and Abraham Morgentaler. “Reply To Julia Klap And Kevin R. Loughlin’s Letter To The Editor Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A New Era Of Testosterone And Prostate Cancer: From Physiology To Clinical Implications. Eur Urol 2014;65:115–23”. European Urology 66.2 (2014): e33. Web.
Graff, Rebecca E et al. “Pre-Diagnostic Circulating Sex Hormone Levels And Risk Of Prostate Cancer By ERG Tumour Protein Expression”. Br J Cancer 114.8 (2016): 939-944. Web.
Seftel, Allen D. “Re: Effects Of Testosterone Treatment In Older Men”. The Journal of Urology (2016): n. pag. Web.

Ornish D, Weidner G, Fair WR et al. Intensive lifestyle changes may affect the progression of prostate cancer. The Journal of Urology. 2005;174:1065-1070.

European Urology, v.21 (1992), pp. 309-14

British Journal of Clinical Pharmacology, v.18 (1984), pp. 461-62

Klinische Endokrinologie, v.98 (1980), pp. 102-08

Minerva Urologica e Nefrologica, v.37 (1985), pp. 87-91

Medical Science Research, v.16 (1983), pp. 1067-68

British Journal of Urology, v.80 (1997), pp. 427-32

Urolage A, v.24 (1985), pp. 49-51

Lancet, v.345 (1995), pp. 1529-32

Minerva Urologica e Nefrologica, v.39 (1987), pp. 45-50

Prostate, v.37 (1998), pp. 187-93

Wiener Klinische Wochenschrift, v.22 (1990), pp. 667-73

Medizinische Klinik, v.77 (1982), pp. 520-22

Journal of the Am. Med.Assn., v.280 (1998), pp. 1604-09

British Journal of Urology, v.78 (1996), pp. 325-36

Current Therapeutic Research, v.55 (1994), pp. 776-85

British Journal of Urology, v.83 (1999), pp. 976-83

British Journal of Urology, v.85 (2000), pp. 842-46

Prostate, v.37 (1998), pp. 77-83

British Journal of Cancer 76 (1997), pp. 678-87

American Journal of Epidemiology 133 (1991), pp. 215-19

Journal of the National Cancer Institute 90 (1998), pp.1219-24

Journal of the National Cancer Institute 92 (2000), pp. 61-68

Journal of the National Cancer Institute 82 (1990), pp. 941-46

Cancer Epidem. Biomarkers and Preview 6 (1997), pp. 487-91

Prostate v.47 (2001), pp. 293-303

Igaku No Ayumi v.103 (1977), pp. 22-24

Cancer Epidem. Biomarkers and Prev. 10 (2001), pp. 861-68